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Reduction of duration of untreated psychosis (DUP) is 
the key strategy of early interventions for improving the 
outcomes of first-episode psychosis. Although several con-
trolled interventional studies have been conducted with the 
aim of reducing DUP, the results are highly inconsistent 
and conflicting. The current study systematically searches 
Web of Science and Ovid for English original arti-
cles investigating interventions adopted to reduce DUP, 
compared to a control intervention, up to April 6, 2017. 
Sixteen controlled interventional studies were retrieved, 
including 1964 patients in the intervention arm and 1358 
in the control arm. The controlled intervention studies 
were characterized by standalone first episode psychosis 
services, standalone clinical high risk services, community 
interventions, healthcare professional training, and multi-
focus interventions. Random effects meta-analyses were 
conducted. There was no summary evidence that availa-
ble interventions are successful in reducing DUP during 
the first episode of psychosis (Hedges’ g  =  −0.12, 95% 
CI = −0.25 to 0.01). Subgroup analyses showed no differ-
ences within each subgroup, with the exception of clinical 
high risk services (Hedges’ g = −0.386, 95% CI = −0.726 
to −0.045). These negative findings may reflect a parceled 
research base in the area, lack of prospective random-
ized controlled trials (only 2 randomized cluster designed 
studies were present) and small sample sizes. There was 
substantial heterogeneity (I2  =  66.4%), most of which 
was accounted by different definitions of DUP onset 
(R2 = .88). Psychometric standardization of DUP defini-
tion, improvement of study design, and implementation of 
preventative strategies seem the most promising avenues 
for reducing DUP and improving outcomes of first-episode 
psychosis.
Key words: duration of untreated psychosis/schizophrenia/ 
first episode/prevention/outcomes/meta-analysis
Introduction
Psychosis is one of the most debilitating psychiatric con-
ditions with limited options to improve outcomes.1 One 
key strategy is reducing the duration of untreated psy-
chosis (DUP), the time from the first symptom of psy-
chosis to the start of treatment.2 Accumulating studies 
have shown that a longer DUP is associated with poorer 
outcomes for people with first-episode psychosis (FEP), 
including worse positive3,4 and negative symptom4,5 sever-
ity, poorer rates of remission,4,6,7 poorer social cogni-
tion,6,8 and cognitive impairment.6,9,10 In addition to the 
clinical, functional, and cognitive benefits, reducing DUP 
is associated with reducing the social consequences of 
psychosis onset, such as social isolation, unemployment, 
homelessness, and can reduce deliberate self  harm11,12 
and violence toward others.12,13 Under standard care, 
DUP tends to be quite long, with means varying between 
22 weeks and over 150 weeks,14 with high heterogeneity 
between patients.15 These long periods without treatment 
arise from several sources, both intrinsic (eg, symptom 
severity, patients’ attitude) and extrinsic (eg, access to 
care).16 These considerations lay foundations for special-
ized early intervention services1 with the aim of improv-
ing early detection and facilitating pathways to care and 
treatment; minimizing DUP.
In recent years, many different interventions have been 
trialed to reduce DUP, targeting different sources of refer-
rals for FEP cases such as general practitioners, service 
providers, and the community. These specific interventions 
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have been varied including programs networking primary 
healthcare providers and public education,17 early detec-
tion programs identifying FEP patients12,18 or those at 
clinical high risk for psychosis (CHR-P),19,20 information 
workshops,21 written information in information packs, 
newsletters or brochures,17,22 community intervention 
teams and activities,18 and websites and telephone hot-
lines.17 Studies have typically compared service providers 
(standalone FEP services or standalone CHR-P services), 
community, healthcare professional training or multifo-
cus (combining other types) interventions to a control 
group. The overall impact of these controlled interven-
tions for reducing the DUP is still undetermined because 
the findings are conflicting.23,24 Earlier reviews suggested 
that interventions reducing DUP held promise for pro-
ducing better outcomes in FEP,16,23 but these studies did 
not combine qualitative and quantitative data synthesis. 
Furthermore, in the years since the last review,16 there 
have been significant additions to the literature.20,25–30
The primary aim of the current study is to systemat-
ically review the conflicting evidence for the impact of 
specific controlled interventions in reducing DUP and 
to provide a meta-analysis measuring their magnitude, 
consistency, determining which type of intervention is 
the most successful, as well as addressing potential con-
founders. These analyses may be particularly informa-
tive for the implementation of early psychosis services 
worldwide.
Methods
Selection Procedures and Data Collection
Search Strategies. PRISMA31 and MOOSE guidelines32 
were adhered to throughout to achieve high quality of 
reporting (supplementary eTables 1 and 2). Details of 
the protocol for systematic review were registered on 
PROSPERO (CRD42017057082).
A 2-step systematic search of the literature was performed 
by 2 independent researchers (S.L. and G.C.) to identify rel-
evant studies investigating the effect of controlled interven-
tions aiming to reduce DUP in early psychosis.16
At a first step, the Web of Science database by Thomson 
Reuters (including Web of Science, BIOSIS Citation Index 
and MEDLINE) and the Ovid database by Wolters Kluwer 
(including MEDLINE and PsycINFO) were searched. 
Keywords used were (“duration of untreated psychosis”) 
AND (intervention OR decreas* or reduc*). The search 
was extended from inception until April 6, 2017.
The second step involved an electronic manual search 
of references found in the included articles. Articles found 
through these steps were then screened on the basis of 
title or abstract reading. Articles that remained were then 
fully downloaded as PDFs and assessed for eligibility on 
the basis of full text reading. Disagreements regarding 
studies fitting inclusion criteria were resolved by consen-
sus with a third researcher (D.O.).
Inclusion Criteria. Articles meeting the inclusion criteria 
for the current systematic review and meta-analysis: (a) 
were original articles or original data presented as con-
ference abstract, written in English, (b) included patients 
diagnosed with a psychotic disorder defined according to 
standard international Diagnostic and Statistical Manual 
of Mental Disorders (DSM) or International Statistical 
Classification of Diseases and Related Health Problems 
(ICD) criteria—any version, (c) were controlled studies 
with either randomized cluster, cohort, or cohort analytic 
designs, and (d) reported DUP as a key outcome measure, 
as defined by each individual article. We did not restrict 
inclusion to any specific study design.
Exclusion Criteria. We excluded (a) pilot datasets, 
reviews, articles in languages other than English, (b) arti-
cles failing to report enough data to perform a meta-analy-
sis (authors were contacted to obtain missing data), and (c) 
studies with overlapping cohorts (only the study with the 
largest sample or most recently published was included).
Recorded Variables. We recorded the following variables 
from each article relating to patients: mean age, gender, 
ethnicity (% white), marital status (proportion of married 
subjects), cannabis abuse/dependence (% meeting abuse/
dependence criteria), alcohol abuse/dependence (% meet-
ing abuse/dependence criteria), living status (%  living 
independently), migrant status (%  nonmigrants), psy-
chotic symptom severity at baseline (PANSS), diagnosis 
(%  schizophrenia); relating to the study: author, length 
of intervention (months) (time intervention was delivered 
to community, healthcare professionals, etc.), quality of 
studies (see below), publication year, continent, healthcare 
system type (Semashko, Bismarck, market-based), type of 
controlled interventions (standalone FEP services, stand-
alone CHR-P services, community interventions, health-
care professional training, and multifocus interventions), 
primary media of intervention (written or audiovisual in-
formation, direct contact or service configuration, defined 
below), study design (randomized cluster, cohort analytic, 
cohort), target of intervention, control DUP, definition of 
DUP onset, definition of DUP endpoint.
The main outcome was DUP in intervention groups and 
control groups. We extracted meta-analytical DUP data 
(see “Statistical Analysis” section) and DUP definitions 
(at onset and endpoint).
Quality Assessment. Evaluation of quality of studies 
was performed using a risk bias tool, an adapted ver-
sion of the Newcastle Ottawa Scale33 (see supplementary 
eMethods 1).
Statistical Analysis
The effect-size measure was Hedges’ g.34 This indexed the 
impact of the specific intervention on the DUP. Negative 
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values indicated reduced DUP in the intervention group 
and positive values indicated reduced DUP in the control 
group. The DUP was primarily measured through mean 
value (in days) and standard deviation (SD) or median value 
(in days) and standard error of the mean (SEM) (when pre-
sented instead of mean and SD) and group size (n). Where 
these values were not available other complementary sta-
tistics allowing the estimation of Hedges’ g were extracted.
Controlled interventional strategies were defined as: 
(a) standalone FEP services, (b) standalone CHR-P serv-
ices, (c) community interventions, (d) healthcare profes-
sional training, and (e) multifocus interventions. These 
subgroups were defined by the systematic review that 
was conducted ahead of the meta-analysis, as indicated 
below. The meta-analyses included an overall estimate 
across all subgroups as well as within-subgroup summary 
effects and between-subgroups effects.
Heterogeneity among study point estimates was 
assessed using Q statistics35 and the proportion of the 
total variability in the effect size estimates evaluated with 
the I2 index.35 Given the methodological heterogeneity of 
the included studies, random effects models36 were em-
ployed using the method of DerSimonian and Laird.37
Risk of publication bias was tested by visual inspection 
of funnel plots in addition to the application of the Egger 
regression intercept method38 and the Duval and Tweedie 
“trim and fill” method.39 To further assess the robustness 
of the results, we performed sensitivity analyses by sequen-
tially removing each study and re-running the analysis.40
To explain any heterogeneity found, meta-regression 
analyses were conducted when at least 10 studies were avail-
able for the specific confounders relating to patients: mean 
age, gender, ethnicity (% white), marital status (proportion 
of married subjects), cannabis abuse/dependence (% meet-
ing abuse/dependence criteria), alcohol abuse/dependence 
(% meeting abuse/dependence criteria), living status (% liv-
ing independently), migrant status (% non-migrants), psy-
chotic symptom severity at baseline (PANSS), diagnosis 
(%  schizophrenia); relating to the study: length of inter-
vention (months), quality of studies (see below), publica-
tion year, continent, healthcare system type (Semashko, 
Bismarck, market-based), study design (randomized clus-
ter, cohort analytic, cohort), control DUP, definition of 
DUP onset, definition of DUP endpoint. When PANSS 
scores were not available for symptom severity, SAPS/
SANS or BPRS scores were converted to PANSS, follow-
ing previously established procedures.41,42
The significance level was set to 0.05 (2-sided). Meta-
analyses were performed using Comprehensive Meta-
Analysis Software version 343 and STATA version 13.44
Results
Database
The flow of articles through the initial literature search, 
including numbers of articles screened, assessed for 
eligibility and included in the review, is summarized in 
the PRISMA plot (figure  1). The search uncovered 14 
independent articles (7 new20,25–30 compared to the pre-
vious systematic search16) in addition to 2 new confer-
ence abstracts.45,46 Five of the previously found studies 
were excluded, one for not including a control group,47 
another for not explicitly reporting DUP22 and 3 for 
overlapping data.23,48,49 The final database comprised 16 
studies including 1964 patients in the intervention arm 
and 1358 in the control arm. All studies used similar defi-
nitions of FEP, with 12 studies defining it according to 
DSM-IV,15,20,21,24–29,45,46,50 2 according to DSM-III-R,17,18 1 
according to ICD-10,51 and 1 employing both ICD-10 and 
DSM-IV30. The mean age of the intervention and control 
groups were 25.5 years (range 21.6–36.6) and 26.4 years 
(range 22.0–38.0), respectively. The mean length of inter-
vention was 31.3  months (range 8–78  months). All the 
studies had either cohort,17,18,24–27,29,30,45,50 cohort ana-
lytic,15,20,28,46 or randomized cluster design.21,51 More 
information on interventions is detailed in table 1.
Systematic Review of the Type of Interventions for 
Reducing the DUP
All included studies were investigating an intervention 
aiming to reduce DUP compared to a control group. 
DUP onset was operationalized as patient report of 
onset of frank psychotic general symptoms in 8 stud-
ies,18,24,25,27,29,30,50,51 as patient report of onset of frank 
psychotic positive symptoms in 4 studies,17,20,26,45 defined 
psychometrically using PANSS in 2 studies15,28 or unre-
mitting psychotic symptoms for greater than 1 week in 
1 study.21 DUP endpoint was operationalized as general 
Fig. 1. PRISMA flow chart.
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Table 1. Description of Included Studies
Initiative
Location 
(Health care 
Provision Type)
Duration of 
Intervention
Intervention,  
n
Control,  
n Age (SD) DUP Definition
FEP 
Definition
Intervention 
Type (Target)
CIEIS29 London, UK 
(Semashko)
12 months 104 66 22.4 (6.3) Retrospective, 
clinical
DSM-IV Community 
intervention 
(Community 
workers— 
non-healthcare)
DETECT25 Dublin, Ireland 
(Bismarck)
78 months 172 151 26.2 
(IQR: 
20.9, 
36.0)
Retrospective, 
clinical
DSM-IV Multifocus 
intervention 
(GPs, general 
public, 
universities)
EASY/JCEP26 Hong Kong 
(Semashko)
12 months 479 122 31.6 (8.4) Retrospective, 
clinical
DSM-IV Community 
intervention 
(general public)
EDEN28 Birmingham, 
UK (Semashko)
18 months 77 74 30.9 Retrospective, 
clinical
DSM-IV Community 
intervention 
(general public, 
patients)
EPIP17 Singapore 
(Bismarck)
2 years 287 107 25.4 (8.5) Retrospective, 
clinical
DSM-III-R Multifocus 
intervention 
(GPs, general 
public, patients, 
patients’ 
families)
EPPIC18 Melbourne, 
Australia 
(Bismarck)
8 months 51 51 22.4 (3.8) Retrospective, 
clinical
DSM-III-R Standalone 
FEP service
EPPIC24 Melbourne, 
Australia 
(Bismarck)
12 months 40 58 22.2 (3.4) Retrospective, 
clinical
DSM-IV Multifocus 
intervention 
(GPs, secondary 
schools)
IMAGES30 Jujuy, Argentina 
(Bismarck)
6 years 53 53 30.7 
(11.1)
Retrospective, 
clinical
DSM-IV/ 
ICD-10
Healthcare 
professional 
training (health 
workers)
LEOCAT21 London, UK 
(Semashko)
27 months 36 35 23.9 
(5.27)
Retrospective, 
psychometric
DSM-IV Healthcare 
professional 
training (GPs)
OASIS20 London, UK 
(Semashko)
5 years 43 147 24.0 (5.5) Prospective, 
psychometric
DSM-IV Standalone 
ARMS service
PAE-TPI46 Barcelona, 
Spain 
(Semashko)
15 months 133 58 - Retrospective, 
clinical
DSM-IV Standalone 
FEP service
PEPP50 Ontario, Canada 
(Semashko)
2 years 85 84 25.0 (7.8) Retrospective, 
clinical
DSM-IV Multifocus 
intervention 
(GPs, general 
public, high 
school students, 
university 
students, 
patients’ 
families)
PEPP27 Ontario, Canada 
(Semashko)
42 months 145 132 24.3 (4.0) Retrospective, 
clinical
DSM-IV Healthcare 
professional 
training (GPs)
REDIRECT51 Birmingham, 
UK (Semashko)
30 months 65 58 22.7 (3.7) Retrospective, 
clinical
ICD-10 Healthcare 
professional 
training (GPs)
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commencement of antipsychotic treatment in 12 stud-
ies,15,17,18,20,21,24–26,28,30,45,51 30  days’ consistent antipsychotic 
medication in 2 studies27,50 or first contact with FEP ser-
vices in 1 study.29 Information on DUP onset and end-
point definition used was missing in one study.46 All but 
one20 defined the DUP retrospectively.15,17,18,21,24–30,45,46,50,51 
Most studies were performed in high-income countries 
on urban populations,15,17,18,20,21,24–29,45,46,50,51 with the only 
exception focusing on a rural population in Argentina.30 
Three studies18,20,46 focused on service configuration alone 
as main type of intervention. Two of these investigated 
the effect of FEP services18,46 with the other focusing on 
the effect of CHR-P services.20 The 2 approaches were 
quite distinct in that the CHR-P service was the only 
one to adopt a longitudinal design. The remaining stud-
ies combined early intervention with education-based 
interventions. Specifically, 3 studies26,28,29 focused entirely 
on community interventions: psychosis awareness cam-
paigns using promotional material for early interven-
tion services, talks, and exhibitions aimed at the public. 
Seventy-five percent of community intervention studies 
combined direct contact with audiovisual promotional 
materials. A further 4 studies21,27,30,51 targeted healthcare 
professionals. All studies emphasized direct contact, par-
ticularly through workshops but only half  incorporated 
audiovisual materials. A  further 6 studies were multifo-
cus interventions, combining different types of service 
configuration with community education campaigns and 
healthcare professional training.15,17,24,25,45,50 It was thus 
possible to cluster the types of controlled interventions 
across 5 subgroups: standalone FEP services, standalone 
CHR-P services, community interventions, healthcare 
professional training, and multifocus interventions (more 
detail on the content of each intervention can be seen in 
supplementary eTable 3).
Meta-Analytical Summary of Interventions for 
Reducing DUP
The overall effect for DUP reduction across all the 
included studies was small (Hedges’ g  =  −0.12, 95% 
CI  =  −0.25 to 0.01) and did not reach significance 
(P  =  .077; figure  2). When only including studies pub-
lished in peer-reviewed journals, there were no significant 
changes (Hedges’ g = −0.07, 95% CI = −0.20 to 0.05).
Subgroups Meta-Analysis of Interventions for 
Reducing DUP
Within-subgroup analysis showed no significant effects 
within 4 of the 5 subgroups (figure 2): multifocus inter-
ventions (Hedges’ g = −0.014; 95% CI = −0.291 to 0.263), 
community interventions (Hedges’ g  =  −0.186; 95% 
CI  =  −0.451 to 0.079), healthcare professional training 
(Hedges’ g = −0.010, 95% CI = −0.173 to 0.152) and stand-
alone FEP service (Hedges’ g = −0.366, 95% CI = −0.821 
to 0.150). Conversely, standalone CHR-P services did 
significantly reduce DUP (Hedges’ g  =  −0.386, 95% 
CI = −0.726 to −0.045). However, this was very under-
powered with only one study. Furthermore, between-sub-
group analyses showed no significant differences across 
the 5 types of intervention (Q = 9.283, df = 4, P = .054).
Heterogeneity, Meta-Regressions, Publication Bias, and 
Sensitivity Analysis
There was substantial heterogeneity present in the meta-
analysis, with an I2 of 66.4% (Q  =  44.697, P < .001, 
df  =  15), which justified conducting meta-regression 
analyses.
Meta-regressions were conducted on (1) complete set 
of studies for length of intervention, publication year, 
Initiative
Location 
(Health care 
Provision Type)
Duration of 
Intervention
Intervention,  
n
Control,  
n Age (SD) DUP Definition
FEP 
Definition
Intervention 
Type (Target)
STEP45 USA 
(market-based)
18 months 53 22 — Retrospective, 
psychometric
DSM-IV Multifocus 
intervention 
(secondary 
schools, GPs, 
acute clinical 
care providers, 
community 
agencies)
TIPS15 Rogaland 
County, Norway 
(Bismarck)
4 years 141 140 28.6 (9.1) Retrospective, 
psychometric
DSM-IV Multifocus 
intervention 
(GPs, general 
public, 
healthcare 
workers)
Note: FEP, first-episode psychosis; DUP, duration of untreated psychosis; DSM, diagnostic and statistical manual of mental disorders; 
ICD, International Statistical Classification of Diseases and Related Health Problems.
Table 1. Continued
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study design and control DUP, (2) n = 15 for quality of 
studies, definition of DUP onset and endpoint, (3) n = 14 
for mean age gender, and (4) n = 10 for marital status. 
Analyses for other factors mentioned in the methods were 
not performed as fewer than 10 studies contributed rele-
vant data. There were no significant effects for the follow-
ing patient-related variables: age (β = −0.022, P = .274), 
gender (β ≤ 0.001, P =  .973), marital status (β = 0.006, 
P  =  .708), or for the following study-related variables: 
length of interventions (β  =  0.002, P  =  .473; figure  3), 
quality of studies (β = 0.070, P = .396), publication year 
(β = −0.012, P = .317), continent (Q = 1.73, P = .786), 
healthcare system type (Q = 1.36, P = .507), study design 
(Q  =  4.13, P  =  .127) or definition of DUP endpoint 
(Q = 1.15, P = .562) see supplementary eFigures. Meta-
regression of control DUP showed that a longer DUP at 
the start of the study was associated with a greater reduc-
tion in DUP (β < −0.001, P = .028). This model explained 
over a third of the total between-study variance (R2 = .37; 
figure 4). However, this effect was mostly driven by 2 out-
liers17,45; when these were removed, the effect was no lon-
ger significant (β < −0.001, P = .115). Meta-regression of 
definition of DUP onset showed that defining the DUP 
onset as the onset of frank psychotic positive symp-
toms or by using the PANSS was associated with a sig-
nificantly greater decrease in DUP compared to other 
onset definitions (β = −0.400, P < .001 and β = −0.480, 
P < .001, respectively) (figure 5). This model explained 
a substantial proportion of total between-study variance 
(R2 = .88). A multivariate meta-regression model includ-
ing control DUP and definition of DUP onset was tested 
but was nonsignificant (P = .0536, R2 = .39).
There was no evidence of publication bias as indicated 
by visual inspection of the funnel plots (supplementary 
eFigures 10 and 11) and by the Egger regression intercept 
(intercept = −0.508, P = .386). Sensitivity analysis did not 
suggest sensitivity of the meta-analytic estimate to the re-
moval of any one study (supplementary eFigure 12), con-
firming the robustness of the findings.
Discussion
This is the first meta-analysis of the impact of controlled 
interventional studies to shorten DUP in FEP. We found 
16 controlled studies investigating interventions to reduce 
DUP in FEP patients. The database was relatively large 
with 1964 patients in intervention groups and 1358 in 
control groups with duration of interventions lasting an 
average of 31.3  months. There was no overall evidence 
that they were effective in reducing the DUP. Within-
subgroup analyses did not provide evidence that stand-
alone FEP services, community interventions, healthcare 
professional training, or multifocus interventions are 
effective in reducing DUP compared to control. Although 
Fig. 2.  Forest plot showing results of random effects within-subgroup analysis and overall summary effect.
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there was some evidence that standalone CHR-P services 
are effective in reducing DUP compared to control, this 
analysis had low power and between-subgroup analy-
sis showed no superiority of any type of intervention. 
There were no publication biases and the results were 
not affected by outliers. The heterogeneous definition 
of DUP onset explained a substantial proportion of the 
observed variance.
The principal finding of  this meta-analysis is lack 
of  overall summary evidence for any beneficial impact 
of  controlled interventions for reducing the DUP. Our 
finding corroborates earlier systematic reviews conclud-
ing that the evidence base for effective reductions of 
DUP was “very limited.”16 Negative findings are always 
difficult to interpret because “absence of  evidence is not 
equivalent to evidence of  absence.”52 However, ours are 
unlikely to be secondary to low power since the anal-
yses are based on a larger sample compared to previ-
ous systematic reviews16 and the overall effect was very 
small in magnitude. Furthermore, the negative findings 
were robust and not due to publication biases or to the 
presence of  outliers. Moreover, when the analyses were 
stratified within and between the different subgroups 
the results were overall unchanged. Within subgroup 
analyses indicated that the lack of  DUP reduction was 
specific to standalone FEP services, community, health-
care professionals training or multifocus interventions. 
The only exception was noted in relation to standalone 
CHR-P services. However, this is the only report avail-
able; these findings should be interpreted cautiously. 
Furthermore, the magnitude of  the effect size for this 
study was still small to medium and between-subgroup 
analysis highlighted no significant effect of  subgroup 
on DUP.
Shortening DUP is influenced by many different fac-
tors. It is possible that the negative findings may be 
the consequence of  substantial heterogeneity both at a 
patient-level and across individual studies. Variation in 
DUP values within each study was high and this raises 
the question of  individuality of  cases and the factors 
that will vary from patient to patient. We attempted to 
address study-level heterogeneity with meta-regression 
analyses on numerous patient related variables (mean 
age, gender, marital status) and study related variables 
(length of  intervention, quality of  studies, publication 
year, continent, study design, and definitions of  DUP 
at endpoint), that revealed no significant effects. We 
found that a shorter start DUP (control DUP) leaves less 
opportunity for reducing DUP, however, this effect was 
very small and influenced by outliers. Conversely, the def-
inition of  DUP onset had a stronger impact on reducing 
DUP, explaining more than half  of  the observed heter-
ogeneity. The definition of  DUP is not precisely opera-
tionalized and still subject to variable ascertainment.16,53 
Defining onset psychometrically using the PANSS or 
with positive symptoms using a clinical instrument was 
linked with a significant reduction in DUP while other 
Fig. 3. Meta-regression analyses. Effect of controlled intervention 
on the DUP (Hedges’ g) by length of intervention (months).
Fig. 4. Meta-regression analyses. Effect of controlled intervention 
on the DUP (Hedges’ g) by control DUP (days).
Fig. 5. Meta-regression analyses. Effect of controlled intervention 
on the DUP (Hedges’ g) by DUP onset definition.
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definitions were not (figure 5). This suggests the useful-
ness of  psychometric and clinical instruments as a way 
of  reliably defining the onset of  DUP. Proper psycho-
metric studies are however required to standardize DUP 
definition. For example, issues have previously been 
raised regarding the pseudospecificity of  the PANSS (eg, 
correlations between different subdomains that are not 
entirely independent).54
The current meta-analysis has some potential clinical 
implications. It highlights that, although the positives 
for reducing DUP seem obvious, accomplishing this is 
difficult. This meta-analysis has not provided convinc-
ing evidence that current approaches to reduce DUP 
are effective in accomplishing their aim, with the poten-
tial exception of CHR-P services. Our findings are par-
ticularly concerning if  interpreted along with the other 
recent meta-analytical negative findings showing that 
specialized early intervention programs based on inte-
grated psychopharmacological, psychoeducational, and 
psychological interventions are not more effective in pre-
venting a relapse following a FEP than standard care.1 
From a purely meta-analytical perspective, these 2 recent 
meta-analyses indicate that despite all efforts, there is not 
yet convincing, robust evidence that early interventions 
in psychosis can reliably reduce DUP or prevent relapse, 
even when cutting edge treatments are implemented 
under well-resourced research scenarios. Although such 
a gloomy figure may shed pessimistic light on the field of 
early interventions in psychosis, our findings should be 
interpreted cautiously. Meta-analyses inherit the method-
ological limitations of the underlying individual studies. 
It is possible that small sample size (over half  of included 
studies had n  <  100 in intervention or control group), 
suboptimal study designs and idiosyncratic interventions 
do not allow retrieval of consistent effects. Indeed, we 
found that the definition of the DUP was unstandard-
ized and associated with significant heterogeneity. Thus, 
it seems clear that some standardization of DUP inter-
vention studies should be on the research agenda for the 
near future. Similarly, differences in how a “first” episode 
is defined could further add heterogeneity, potentially 
referring to first contact with services for a psychotic 
disorder, first adequate treatment for a psychotic disor-
der or presenting within a specific amount of time since 
symptom onset.55 Furthermore, since there are many dif-
ferences between interventions, even within subgroups, 
standardization would greatly benefit future comparabil-
ity analyses. While 2 studies employed randomized clus-
ter designs,21,51 no randomized controlled trials (RCTs) 
were found in the search, which is unsurprising given the 
difficulties in performing them. Randomization at the 
patient level is logistically complex, randomized cluster-
ing is more viable as randomization is performed at the 
practice level. Moreover, the ethics of withholding inter-
ventions with no discernible adverse effects from FEP 
patients is complicated, particularly those relating to the 
critical loss period56: the intervention only has benefit 
before endpoint of treatment, so the patient can derive 
no benefit after study completion. Despite the difficul-
ties in implementing randomized clustering trials into the 
field, it is important at least to improve the consistency 
and comparability between studies. These issues can only 
be tackled by large-scale collaborations across research 
consortia. Overall, there is a clear implementation gap to 
be filled for extending the benefits of early interventions 
in psychosis.57 However, meta-regression on study design 
showed no significant reduction in DUP when random 
clustering was used compared to other designs, though 
power was low.
A final clinical consideration relates to the potential 
role of psychosis prevention. As highlighted by our within 
subgroup analysis, the CHR-P approach has unique 
potential for altering the DUP and therefore the course 
of psychosis.58 Controlled interventions in CHR-P serv-
ices can be highly effective as they can tackle some of 
the limitations above. The study investigating the effect 
of CHR-P services20 is unique as it adopts a prospec-
tive, longitudinal design. Consequently, the accuracy of 
DUP definition is the highest in this scenario and was 
operationalized with standardized psychometric instru-
ments such as the Comprehensive Assessment of At Risk 
Mental State (CAARMS, version 12/2006), which accu-
rately estimate timing of onset of attenuated and frank 
psychotic symptoms prospectively.59 Future controlled 
randomized interventional studies could use similar psy-
chometric instruments to define the DUP. Importantly, in 
this study, the average DUP for those who had contacted 
CHR-P services was 11.2 days compared to 366.5 in FEP 
services.20 Beyond DUP reduction, the CHR-P services 
further allow for primary indicated prevention, halving 
the risk of progression to psychosis.60 This may be particu-
larly important,57 given the lack of robust effects on DUP 
reduction at the FEP stage. A  third benefit of CHR-P 
services may extend to those already identified as FEP at 
the time of the initial CHR-P assessment. In fact, com-
pared to patients accessing FEP services, patients who 
presented in the CHR-P stage are also less likely to require 
admission following the onset of psychosis (46% vs 68%) 
and less likely to require a compulsory admission in the 
short-term (30% vs 62%).61 However, the implementation 
of indicated prevention strategies in mental healthcare is 
still limited and not widely accessible57,62 and, moreover, 
there is recent evidence indicating that only about half of 
first episode patients have experienced CHR-P symptoms 
before illness onset.63 Furthermore, new interventional 
studies in children and adolescents are needed to clarify 
potential benefits of DUP reduction in earlier stages.
However, beyond their effectiveness on DUP reduc-
tion, early psychosis services have been crucial in chang-
ing how mental health and mental healthcare are viewed 
worldwide.53 Even if  not (yet) robustly justified by 
meta-analytical data, such initiatives provide humane, 
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trust-engendering support to patients and families at a 
difficult moment in their lives.64
Conclusion
This meta-analysis provides a significant quantitative 
summary of current evidence for interventions to reduce 
DUP during FEP. It shows a lack of robust evidence that 
specific interventions such as standalone FEP services, 
community interventions, healthcare professional train-
ing, and multifocus interventions are successful in accom-
plishing this. While this finding is negative, there is some 
evidence that initiatives to reduce DUP may be effective 
in areas where the DUP is particularly long. Some evi-
dence is also emerging for CHR-P services but it is not 
replicated. Collaborative large-scale initiatives adopting 
well standardized psychometric definitions of DUP and 
refined study designs are needed to advance knowledge 
and improve outcomes of FEP.
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Supplementary data are available at Schizophrenia 
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